Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Novel Hypothermic Preservation Formulation Containing SUL-138 Enables Long-Term Hypothermic Storage of Clinical-Grade CAR-T Cells.

Pharmaceutics·2026

Same author

Dermal Fibroblasts Modulate Migration and Phenotype of Infiltrating Monocytes in Skin-Derived Extracellular Matrix Hydrogels.

Gels (Basel, Switzerland)·2026

Same author

Stiffness-induced destabilization of adherens junctions inhibits vascular network formation by pulmonary endothelial cells in lung-derived extracellular matrix hydrogels.

Biomaterials·2026

Same author

Piezo1 regulates remodeling of skin-derived extracellular matrix by embedded umbilical cord mesenchymal stem cells in a stiffness-dependent fashion.

Materials today. Bio·2026

Same author

Absorption, distribution, metabolism and excretion of SUL-138 in rats and minipigs.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Published on: April 13, 2012

Endothelial progenitor cell-based neovascularization: implications for therapy.

Guido Krenning¹, Marja J A van Luyn, Martin C Harmsen

¹Stem Cell and Tissue Engineering Research Group, Department Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 (EA11), NL-9713GZ Groningen, The Netherlands.

Trends in Molecular Medicine

|March 24, 2009

Summary

Endothelial progenitor cells (EPCs) aid vascular repair by releasing factors that stimulate new blood vessel growth. Future therapies may use these factors directly for regenerative medicine.

More Related Videos

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

Related Experiment Videos

Last Updated: Jun 24, 2026

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Published on: April 13, 2012

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

Area of Science:

Cardiovascular Research
Regenerative Medicine
Endothelial Biology

Background:

Ischemic cardiovascular events represent a significant global health burden.
Endothelial progenitor cell (EPC) therapies show potential for improving vascular perfusion.
The precise mechanism of EPC action, particularly long-term engraftment, remains debated.

Purpose of the Study:

To review the role of EPCs in neovascularization following ischemic injury.
To elucidate the paracrine mechanisms by which EPCs promote angiogenesis.
To explore the therapeutic potential of EPC-secreted factors in vascular regenerative medicine.

Main Methods:

Review of existing literature on EPCs and neovascularization.
Analysis of the (patho)physiology of EPC-mediated angiogenesis.
Focus on paracrine signaling pathways activated by EPCs.

Main Results:

EPCs appear to induce neovascularization primarily through paracrine secretion of cytokines and growth factors.
These secreted factors stimulate sprouting angiogenesis by the surrounding endothelium.
Direct long-term engraftment of EPCs into neovessels is not consistently observed.

Conclusions:

The paracrine action of EPCs is a key mechanism for promoting neovascularization.
Targeting these paracrine signals offers a promising therapeutic strategy.
Slow-release formulations of paracrine modulators could advance vascular regenerative medicine.